Summary
In this article, pediatric melanoma cases treated with Mohs Micrographic Surgery (MMS) were analyzed retrospectively, revealing consistent surgical frequency over time and predominantly early-stage, privately insured patients. Despite MMS benefits, its utilization remains low in pediatric populations, suggesting the need to address barriers to access.
Did you find this helpful?
Thank you for your feedback!
Posted in Mohs
